# S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults

> **NCT00110747** · PHASE3 · COMPLETED · sponsor: **ZARS Pharma Inc.** · enrollment: 54 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)
- **DRUG:** Placebo Peel

## Key facts

- **NCT ID:** NCT00110747
- **Lead sponsor:** ZARS Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2012-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110747, "S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00110747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*